Abbott India reports strong profit growth in Q2 2025

Abbott India Limited reported unaudited financial results for the quarter ended September 30, 2025, with profit for the period reaching INR 415.27 Crores, a notable increase from INR 358.61 Crores in the same quarter last year. Revenue from operations also saw healthy growth, climbing to INR 1,757.15 Crores compared to INR 1,632.67 Crores in Q2 2024. Total income for the quarter stood at INR 1,827.10 Crores.

For the six months ended September 30, 2025, the company's profit for the period was INR 781.13 Crores, up from INR 686.62 Crores in the corresponding period of 2024. Revenue from operations for the half-year reached INR 3,495.50 Crores, an increase from INR 3,190.28 Crores year-on-year. Basic/diluted earnings per equity share for the quarter were INR 195.42, and for the six months, they were INR 367.59.

The board of directors approved these unaudited financial results during their meeting on November 6, 2025. These results were reviewed by Walker Chandiok & Co. LLP, the statutory auditors, and confirm the company’s solid operational and financial health.